# RAB6D

## Overview
RAB6D is a gene that encodes a protein belonging to the RAS oncogene family, specifically involved in intracellular vesicle trafficking. The protein, RAB6D, is categorized as a small GTPase, which plays a critical role in the regulation of vesicular transport and Golgi organization. It is implicated in various cellular processes, including the EGF/MAPK signaling pathway, and has been identified as part of the RNA interactome in the context of SARS-CoV-2 infection, suggesting its involvement in viral replication and host cell responses (Schmidt2020A). The protein's interactions with effector proteins such as dynactin 6 and syntaxin 8 are essential for maintaining Golgi ribbon organization, highlighting its significance in cellular transport mechanisms (Liu2016Identification). Alterations in the expression and mutations of the RAB6D gene have been associated with diseases such as prostate cancer and atherosclerosis, underscoring its potential as a biomarker or therapeutic target (Steffensen2022Somatic; AviñaPadilla2022Deciphering).

## Clinical Significance
The RAB6D gene, a member of the RAS oncogene family, has been implicated in various diseases through its altered expression and mutations. In prostate cancer (PRAD), RAB6D is specifically downregulated, suggesting a potential role in the molecular pathology of the disease. This downregulation may affect amino acid metabolism, which is crucial for cancer cell growth and survival (AviñaPadilla2022Deciphering).

In the context of atherosclerosis, a mutation in the RAB6D gene was identified in atherosclerotic plaques from a patient, with a clone cell frequency of 13%. This finding indicates the presence of clonal cell populations within the plaques, although the specific clinical significance of RAB6D mutations in atherosclerosis remains unclear (Steffensen2022Somatic).

While the exact mechanisms by which RAB6D contributes to these conditions are not fully understood, its involvement in intracellular vesicle trafficking suggests that disruptions in this process could lead to pathological states. The role of RAB6D in cancer and atherosclerosis highlights the importance of further research to elucidate its potential as a biomarker or therapeutic target.

## Interactions
RAB6D, a member of the RAS oncogene family, is involved in intracellular vesicle trafficking and interacts with various proteins, influencing cellular processes. In the context of SARS-CoV-2 infection, RAB6D has been identified as part of the expanded RNA interactome, suggesting its involvement in the EGF/MAPK signaling pathway. This indicates potential physical interactions between RAB6D and viral proteins, which may influence viral replication and host cell responses (Schmidt2020A).

In studies focusing on Golgi organization, RAB6D, also referred to as Rab41/6d, has been shown to interact with specific effector proteins. A yeast two-hybrid screen identified 102 proteins interacting with the GTP-locked form of Rab41/6d, including dynactin 6 and syntaxin 8. These proteins preferentially bind to the GTP-locked form of Rab41/6d, suggesting a physiological interaction that is crucial for maintaining Golgi ribbon organization. The depletion of dynactin 6 or syntaxin 8 results in Golgi fragmentation, similar to the effects observed with Rab41/6d knockdown, highlighting their role as key effectors (Liu2016Identification). These interactions underscore the importance of RAB6D in cellular transport and signaling pathways.


## References


1. (Steffensen2022Somatic) Somatic mutations reveal clonal cell populations in atherosclerotic plaques. This article has 3 citations.

2. (Schmidt2020A) A direct RNA-protein interaction atlas of the SARS-CoV-2 RNA in infected human cells. This article has 12 citations.

[3. (AviñaPadilla2022Deciphering) Katia Aviña-Padilla, José Antonio Ramírez-Rafael, Octavio Zambada-Moreno, Gabriel Emilio Herrera-Oropeza, Guillermo Romero, Ishaan Gupta, and Maribel Hernández-Rosales. Deciphering the Tissue-Specific Regulatory Role of Intronless Genes Across Cancers, pages 311–339. Springer International Publishing, 2022. URL: http://dx.doi.org/10.1007/978-3-031-06220-9_18, doi:10.1007/978-3-031-06220-9_18. This article has 0 citations.](https://doi.org/10.1007/978-3-031-06220-9_18)

[4. (Liu2016Identification) Shijie Liu, Waqar Majeed, Tetyana Kudlyk, Vladimir Lupashin, and Brian Storrie. Identification of rab41/6d effectors provides an explanation for the differential effects of rab41/6d and rab6a/a’ on golgi organization. Frontiers in Cell and Developmental Biology, March 2016. URL: http://dx.doi.org/10.3389/fcell.2016.00013, doi:10.3389/fcell.2016.00013. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fcell.2016.00013)